Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Establishment of Human Adipose Tissue-Derived Stromal Cell Lines: A Culture System to Manufacture Megakaryocytes Releasing Functional Platelets

Keiichi Tozawa, MD, Yukako Ono-Uruga, MD PhD, Noriko Takizawa, Tadashi Horiuchi, Shin-ichiro Okamoto, MD PhD, Mitsuru Murata, MD PhD, Yasuo Ikeda, MD PhD, Yumiko Matsubara, PhD

Blood (2015) 126 (23): 656.

https://doi.org/10.1182/blood.V126.23.656.656

Published: 2015

Journal Articles

Macrophage Colony-Stimulating Factor Attenuated the Severity of Chronic Graft-Versus-Host Disease after Unrelated Bone Marrow Transplantation

Fumihiko Kimura, Ken Sato, Hideki Akiyama, Hiroshi Sao, Shin-ichiro Okamoto, MD, PhD, Naoki Kobayashi, Masamichi Hara, Keisei Kawa, Kazuo Motoyoshi

Blood (2008) 112 (11): 463.

https://doi.org/10.1182/blood.V112.11.463.463

Published: 2008

Journal Articles

Obesity Is Associated with An Increased Risk of Infectious Diseases after Unrelated Bone Marrow Transplantation

Shigeo Fuji, MD, Sung-Won Kim, MD, Ken-ichi Yoshimura, PhD, Hideki Akiyama, MD, Shin-ichiro Okamoto, MD, Hiroshi Sao, MD, Junko Takita, MD, Naoki Kobayashi, MD, Shin-ichiro Mori, MD

Blood (2008) 112 (11): 4346.

https://doi.org/10.1182/blood.V112.11.4346.4346

Published: 2008

Journal Articles

Post-Marketing Surveillance of Bortezomib Treatment for Multiple Myeloma (MM) in Japan: Results of Interim Analysis by the Velcade Japan Proper Use Guideline Committee

Shinsuke Iida, MD, Harumi Yamamoto Mukai, MD, PhD, Kazuma Ohyashiki, MD, PhD, Kensei Tobinai, MD, PhD, Shin-ichiro Okamoto, MD, PhD, Michinori Ogura, MD, PhD, Takayuki Ishikawa, MD, PhD, Kiyohiko Hatake, MD, PhD, Tomomitsu Hotta, MD

Blood (2008) 112 (11): 5198.

https://doi.org/10.1182/blood.V112.11.5198.5198

Published: 2008

Journal Articles

Hepatocyte Growth Factor-Producing Multiple Myeloma (HGF myeloma) Is a Distinct Clinical Entity and Needs for Molecular Targeted Therapy.

Yutaka Hattori, Shin-ichiro Okamoto, MD, PhD, Wenlin Du, Taketo Yamada, Naoki Shimada, Kunio Matsumoto, Morihiko Sagawa, Yasuo Ikeda

Blood (2008) 112 (11): 1717.

https://doi.org/10.1182/blood.V112.11.1717.1717

Published: 2008

Journal Articles

Contribution of T-Cell Reconstitution during the Early Phase after Cord Blood Transplantation to Favorable Clinical Outcomes.

Satoshi Takahashi, MD, Nobukazu Watanabe, MD, Jun Ooi, MD, Akira Tomonari, MD, Kashiya Takasugi, MD, Michihiro Uchiyama, MD, Takaaki Konuma, MD, Muneyoshi Futami, MD, Yoshinori Yamanishi, MD, Keisuke Takahashi, Arinobu Tojo, MD, Tokiko Nagamura, MD, Tsuneo A. Takahashi, PhD, Takehiko Mori, MD, Shin-ichiro Okamoto, MD, Hiromitsu Nakauchi, MD, Shigetaka Asano, MD

Blood (2004) 104 (11): 2227.

https://doi.org/10.1182/blood.V104.11.2227.2227

Published: 2004

NARROW

Establishment of Human Adipose Tissue-Derived Stromal Cell Lines: A Culture System to Manufacture Megakaryocytes Releasing Functional Platelets

Macrophage Colony-Stimulating Factor Attenuated the Severity of Chronic Graft-Versus-Host Disease after Unrelated Bone Marrow Transplantation

Obesity Is Associated with An Increased Risk of Infectious Diseases after Unrelated Bone Marrow Transplantation

Post-Marketing Surveillance of Bortezomib Treatment for Multiple Myeloma (MM) in Japan: Results of Interim Analysis by the Velcade Japan Proper Use Guideline Committee

Hepatocyte Growth Factor-Producing Multiple Myeloma (HGF myeloma) Is a Distinct Clinical Entity and Needs for Molecular Targeted Therapy.

Contribution of T-Cell Reconstitution during the Early Phase after Cord Blood Transplantation to Favorable Clinical Outcomes.

Email alerts

ASH Publications

American Society of Hematology

Establishment of Human Adipose Tissue-Derived Stromal Cell Lines: A Culture System to Manufacture Megakaryocytes Releasing Functional Platelets

Macrophage Colony-Stimulating Factor Attenuated the Severity of Chronic Graft-Versus-Host Disease after Unrelated Bone Marrow Transplantation

Obesity Is Associated with An Increased Risk of Infectious Diseases after Unrelated Bone Marrow Transplantation

Post-Marketing Surveillance of Bortezomib Treatment for Multiple Myeloma (MM) in Japan: Results of Interim Analysis by the Velcade Japan Proper Use Guideline Committee

Hepatocyte Growth Factor-Producing Multiple Myeloma (HGF myeloma) Is a Distinct Clinical Entity and Needs for Molecular Targeted Therapy.

Contribution of T-Cell Reconstitution during the Early Phase after Cord Blood Transplantation to Favorable Clinical Outcomes.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only